Table of Contents As a result of this acquisition, the consolidated financial statements of the Company at December 31, <strong>20</strong>11 and <strong>20</strong>10 inclu<strong>de</strong> the balance sheet of FASA at those dates, as well as its results of operations as of the date on which the Company took control over FASA. At December 31, <strong>20</strong>10, the audited consolidated balance sheet of FASA and its subsidiaries, which inclu<strong>de</strong>s the adjustments discussed in Note 3 a) to restate the <strong>20</strong>10 audited financial statements, reflected the following con<strong>de</strong>nsed financial information, translated in accordance with Mexican FRS. December 31, <strong>20</strong>10 Current assets Ps. 4,954,691 Property and equipment, net 2,135,057 Deferred charges 279,830 Other assets 577,833 Intangible assets 1,836,709 Total assets Ps. 9,784,1<strong>20</strong> Current liability Ps. 5,985,221 Noncurrent liability 2,370,489 Stockhol<strong>de</strong>rs’s equity 1,428,410 Total liabilities and stockhol<strong>de</strong>rs’s equity Ps. 9,784,1<strong>20</strong> The con<strong>de</strong>nsed results of operations of FASA from the acquisition date to December 31, <strong>20</strong>10, translated in accordance with Mexican FRS were as follows: Amounts Net sales Ps. 4,280,919 Operating income 83,763 Loss before taxes on earnings (125,351) Net loss (125,578) The acquisition of FASA is a strategy of the Company to invest in the pharmaceutical product distribution industry through retailers. FASA sells personal care and hygiene products, beauty products, products for babies, and photography <strong>de</strong>veloping services, among other products and services. FASA operates in Chile, Mexico, and Peru through Farmacias Ahumada, S. A., Farmacias Benavi<strong>de</strong>s, S.A.B. <strong>de</strong> C. V., and Farmacias Peruanas, S.A., respectively. F-14
Table of Contents Proforma con<strong>de</strong>nsed financial information of results (unaudited) In accordance with Mexican FRS, the Group presents pro forma con<strong>de</strong>nsed statements of income at December 31, <strong>20</strong>10, whereby the acquisition of FASA goes into effect as if it had occurred on January 1, <strong>20</strong>10. This is based on the information available which is consi<strong>de</strong>red reasonable. The pro forma financial information presented is not a reflection of the results that would have been obtained if the transactions had occurred effectively at the beginning of the year, and it should not be construed as representative of future results. <strong>20</strong>10 <strong>Grupo</strong> <strong>Casa</strong> <strong>Saba</strong> Farmacias Ahumada <strong>Grupo</strong> <strong>Casa</strong> <strong>Saba</strong> Proforma Net sales Ps. 28,933,851 Ps. 19,874,248 Ps. 48,808,099 Cost of sales 25,395,827 14,957,<strong>20</strong>2 40,353,029 Operating expenses 2,937,189 4,671,073 7,608,262 Other (income) expenses, net (58,048) 125,505 67,457 Comprehensive gain or loss on financing, net 221,350 217,395 438,745 Equity on income of associates (6,222) (6,222) Taxes on earnings 65,983 (44,140) 21,843 Net income (loss) Ps 371,550 Ps. (46,565) Ps. 324,985 c) On January 12, <strong>20</strong>12, the Company sold the total shares representative of the capital stock of Farmacias Peruanas, S.A. and Drogueria La Victoria, S.A.C. (jointly FASA Peru), which represented 100 percent of the shares issued and outstanding of those Companies. The sale was ma<strong>de</strong> through FASA Investment, Ltda. and ABF Administradora <strong>de</strong> Beneficios Farmaceuticos, S.A. The selling price amounted to USD $13,000,000 (equivalent to Ps. 181,723). In addition, on January 12 and 13, <strong>20</strong>12, the Company finalized the following agreements: (i) FASA transferred the patent rights of certain tra<strong>de</strong>marks names, whose consi<strong>de</strong>ration amounted to USD $8,000,000 (equivalent to Ps. 111,830); and (ii) the entities of the Group assumed the obligation of not carrying out business activities related to the distribution of pharmaceutical products to the general public in Peru and Bolivia for a five year period, beginning January <strong>20</strong>, <strong>20</strong>12. The consi<strong>de</strong>ration amounted to USD $29,500,000 (equivalent to Ps. 412,312). In the <strong>de</strong>termination of this significant sale, Management consi<strong>de</strong>red all qualitative and quantitative circumstances that encompass the business activity of FASA Peru. Consequently, the assets and liabilities of FASA Peru are presented in the balance sheet at December 31, <strong>20</strong>11 and <strong>20</strong>10 as “discontinued operations” in current and noncurrent assets and liabilities, as the case may be. Moreover, the operations of FASA Peru inclu<strong>de</strong>d in the statements of income for the periods extending from January 1 up to December 31, <strong>20</strong>11 and from October 3 (acquisition date of FASA Peru) up to December 31, <strong>20</strong>10 were reclassified to the line item “discontinued operations”. The con<strong>de</strong>nsed information of the balance sheets of the discontinued operation of FASA Peru, was as follows: <strong>20</strong>11 <strong>20</strong>10 Current assets Ps. 400,067 Ps. 457,561 Property and equipment, net 211,484 179,550 Other noncurrent assets 14,115 16,300 Goodwill 239,008 239,008 Tra<strong>de</strong>marks 245,000 245,000 709,607 679,858 Total assets of discontinued operation 1,109,674 1,137,419 Current liabilities 473,663 608,671 Long-term liabilities of discontinued opertions 792 609 Total liabilities of discontinued operation 474,455 608,280 Net assets of discontinued operation Ps. 635,219 Ps. 528,139 F-15
- Page 1 and 2:
UNITED STATES SECURITIES AND EXCHAN
- Page 3 and 4:
TABLE OF CONTENTS PART I Item 1. Id
- Page 5 and 6:
Table of Contents We caution you th
- Page 7 and 8:
Table of Contents Year ended Decemb
- Page 9 and 10:
Table of Contents To the extent tha
- Page 11 and 12:
Table of Contents We Provide Remote
- Page 13 and 14:
Table of Contents We Are a Holding
- Page 15 and 16:
Table of Contents Today, the market
- Page 17 and 18:
Table of Contents Any future deprec
- Page 19 and 20:
Table of Contents Risk Factors Rela
- Page 21 and 22:
Table of Contents In August 2009, A
- Page 23 and 24:
Table of Contents In April of 2008,
- Page 25 and 26:
Table of Contents The Acquisition h
- Page 27 and 28:
Table of Contents On September 19,
- Page 29 and 30:
Table of Contents On September 19,
- Page 31 and 32:
Table of Contents At our annual gen
- Page 33 and 34:
Table of Contents We distribute the
- Page 35 and 36:
Table of Contents In our stores, we
- Page 37 and 38:
Table of Contents Prior to 2008, th
- Page 39 and 40:
Table of Contents In 2011, we conti
- Page 41 and 42:
Table of Contents To better serve s
- Page 43 and 44:
Table of Contents ● Mexsana talcu
- Page 45 and 46:
Table of Contents Payments and Coll
- Page 47 and 48:
Table of Contents Information Techn
- Page 49 and 50:
Table of Contents In addition to th
- Page 51 and 52:
Table of Contents (3) In Mexico, ph
- Page 53 and 54:
Table of Contents (4) To calculate
- Page 55 and 56:
Table of Contents We also offer our
- Page 57 and 58:
Table of Contents The devaluation o
- Page 59 and 60:
Table of Contents (****) Associates
- Page 61 and 62:
Table of Contents In January 2009 w
- Page 63 and 64:
Table of Contents In our Retail Pha
- Page 65 and 66:
Table of Contents Inflation and Int
- Page 67 and 68:
Table of Contents With the acquisit
- Page 69 and 70:
Table of Contents Results of Operat
- Page 71 and 72:
Table of Contents Net Income. The G
- Page 73 and 74:
Table of Contents On March 25, 2010
- Page 75 and 76:
Table of Contents Grupo Casa Saba i
- Page 77 and 78:
Table of Contents In the event that
- Page 79 and 80:
Table of Contents Grupo Casa Saba h
- Page 81 and 82:
Table of Contents Prior to the noti
- Page 83 and 84:
Property and equipment Our balance
- Page 85 and 86:
Labor obligations Our labor liabili
- Page 87 and 88:
Tax and legal contingencies We are
- Page 89 and 90:
FRS C-4. “Inventories” (FRS C-4
- Page 91 and 92:
Table of Contents As of the transit
- Page 93 and 94: Table of Contents Name and Date of
- Page 95 and 96: Table of Contents Employee Profit S
- Page 97 and 98: Table of Contents The Chairman of t
- Page 99 and 100: Table of Contents All related party
- Page 101 and 102: Table of Contents Significant Chang
- Page 103 and 104: Table of Contents The table below s
- Page 105 and 106: Table of Contents ● ● ● ● a
- Page 107 and 108: Table of Contents ● ● ● ●
- Page 109 and 110: Table of Contents Directors Under t
- Page 111 and 112: Table of Contents Forfeiture of Sha
- Page 113 and 114: Table of Contents We are organized
- Page 115 and 116: Table of Contents Ownership by non-
- Page 117 and 118: Table of Contents ● Gain on sales
- Page 119 and 120: Table of Contents We anticipate tha
- Page 121 and 122: Table of Contents As a foreign priv
- Page 123 and 124: Table of Contents Item 12. Item 12A
- Page 125 and 126: Table of Contents During the review
- Page 127 and 128: Table of Contents Since we are Mexi
- Page 129 and 130: Table of Contents PART III Item 17.
- Page 131 and 132: Table of Contents INDEX TO CONSOLID
- Page 133 and 134: Table of Contents REPORT OF INDEPEN
- Page 135 and 136: Table of Contents ATTESTATION REPOR
- Page 137 and 138: Table of Contents Grupo Casa Saba,
- Page 139 and 140: Table of Contents Grupo Casa Saba,
- Page 141 and 142: Table of Contents NOTES TO THE CONS
- Page 143: Table of Contents a) Through an ass
- Page 147 and 148: Table of Contents 3. Significant ac
- Page 149 and 150: Table of Contents The errors accoun
- Page 151 and 152: Table of Contents Investments in as
- Page 153 and 154: Table of Contents Effective 2011, t
- Page 155 and 156: Table of Contents The Company recog
- Page 157 and 158: Table of Contents The Group has cre
- Page 159 and 160: Table of Contents In addition, the
- Page 161 and 162: Table of Contents Foreign currency
- Page 163 and 164: Table of Contents 8. Derivative fin
- Page 165 and 166: Table of Contents 10. Goodwill, int
- Page 167 and 168: Table of Contents At December 31, 2
- Page 169 and 170: Table of Contents On January 25 and
- Page 171 and 172: Table of Contents 13. Other payable
- Page 173 and 174: Table of Contents 15. Foreign curre
- Page 175 and 176: Table of Contents On December 18, 2
- Page 177 and 178: Table of Contents c) Tax loss carry
- Page 179 and 180: Table of Contents All significant t
- Page 181 and 182: Table of Contents On December 7, 20
- Page 183 and 184: Table of Contents ● ● For real
- Page 185 and 186: Table of Contents 22. Differences b
- Page 187 and 188: Table of Contents ii) For Mexican F
- Page 189 and 190: Table of Contents At December 31, 2
- Page 191 and 192: Table of Contents 23. Reconciliatio
- Page 193 and 194: Table of Contents 24. Supplementary
- Page 195 and 196:
Table of Contents g) Quantitative a
- Page 197 and 198:
Table of Contents ● In October 20
- Page 199 and 200:
Table of Contents Page Representati
- Page 201 and 202:
CREDIT AGREEMENT (THIS “AGREEMENT
- Page 203 and 204:
(k) To the best of its knowledge, F
- Page 205 and 206:
(aa) Any and all funds used by it t
- Page 207 and 208:
“Authorized Officer” shall mean
- Page 209 and 210:
“Drawdown” shall mean each draw
- Page 211 and 212:
“Interest Payment Date” has the
- Page 213 and 214:
“Share Pledge Agreement” shall
- Page 215 and 216:
(g) The Lenders shall credit the am
- Page 217 and 218:
(e) If the Borrower defaults with a
- Page 219 and 220:
(iii) concurrently with the deliver
- Page 221 and 222:
(j) Maintenance of Property. The Bo
- Page 223 and 224:
(ii) To the extent permitted by the
- Page 225 and 226:
(ii) date thereof; Liens imposed by
- Page 227 and 228:
ARTICLE THIRTEEN. Conditions Preced
- Page 229 and 230:
(xxii) neither the execution of the
- Page 231 and 232:
(i) Insolvency. (i) If the Borrower
- Page 233 and 234:
(b) If as a result of the amendment
- Page 235 and 236:
(B) The Chilean Collateral Agent. (
- Page 237 and 238:
(iii) Neither the Chilean Collatera
- Page 239 and 240:
(h) Effective Term. Unless revoked
- Page 241 and 242:
(c) effective. Absent written notic
- Page 243 and 244:
This Credit Agreement is executed i
- Page 245 and 246:
The Chilean Collateral Agent: HSBC
- Page 247 and 248:
(c) If the Central Bank of Mexico s
- Page 249 and 250:
Joint and Several Obligations. (a)
- Page 251 and 252:
(k) Material Adverse Effect. If the
- Page 253 and 254:
Exhibit 4.3 SUMMARY OF THE IRREVOCA
- Page 255 and 256:
(6) defend, at its own cost and exp
- Page 257 and 258:
(5) the balance remaining after the
- Page 259 and 260:
In addition, articles Three, Four a
- Page 261 and 262:
(j) deliver, within five (5) days f
- Page 263 and 264:
Governing Law and Jurisdiction. Thi
- Page 265 and 266:
Servicios Corporativos Doctorgen, S
- Page 267 and 268:
Exhibit 12.2 CERTIFICATION I, Juan